Stir-baked Fructus gardeniae (L.) extracts inhibit matrix metalloproteinases and alter cell morphology

Journal of Ethnopharmacology

Volumn 117, Issue 2, 2008, Pages 285-289

  Yang, Jin gang ^a   Shen, Ye hua ^b   Hong, Yuan ^a   Jin, Feng hai ^a   Zhao, Shu hua ^a   Wang, Ming cui ^a   Shi, Xiu juan ^a   Fang, Xue xun ^a  

^a JILIN UNIVERSITY   (China)

^b NORTHWEST UNIVERSITY   (China)

Author keywords

Chinese herbal formulation; Matrix metalloproteinases (MMPs); Stir baked Fructus gardeniae; Three dimensional (3 D) cell culture

Indexed keywords

CHINESE DRUG; FRUCTUS GARDENIAE EXTRACT; HERBACEOUS AGENT; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE 16; UNCLASSIFIED DRUG; WATER;

ARTICLE; CELL GROWTH; CELL STRUCTURE; CHINESE MEDICINE; DRUG ACTIVITY; DRUG INHIBITION; DRUG MECHANISM; HUMAN; HUMAN CELL; IC 50;

CELL LINE, TUMOR; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUGS, CHINESE HERBAL; GARDENIA; HUMANS; MATRIX METALLOPROTEINASES; PLANT EXTRACTS; PROTEASE INHIBITORS; TETRAZOLIUM SALTS; THIAZOLES;

EID: 41949128617     PISSN: 03788741     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jep.2008.01.033     Document Type: Article

References (21)

1. Baker A.H., Edwards D.R., and Murphy G. Metalloproteinase inhibitors: biological actions and therapeutic opportunities. Journal of Cell Science 115 (2002) 3719-3727
2. Cha B.Y., Park C.J., Lee D.G., Lee Y.C., Kim D.W., Kim J.D., Seo W.G., and Kim C.H. Inhibitory effect of methanol extract of Euonymus alatus on matrix metalloproteinase-9. Journal of Ethnopharmacology 85 (2003) 163-167
3. Demeule M., Brossard M., Page M., Gingras D., and Beliveau R. Matrix metalloproteinase inhibition by green tea catechins. Biochimica et Biophysica Acta 1478 (2000) 51-60
4. Engel L.W., and Straus S.E. Development of therapeutics; opportunities within complementary and alternative medicine. Nature Reviews/Drug Discovery March 1 (2002) 229-237
5. Frisk T., Rydholm S., Andersson H., Stemme G., and Brismar H. A concept for miniaturized 3-D cell culture using an extracellular matrix gel. Electrophoresis 26 (2005) 4751-4758
6. Ha K.T., Lee T.K., Kwaka K.H., Kima J.K., Kima D.I., Choi D.Y., and Kim C.H. Inhibitory effect of Cho-Deung-San on human aortic smooth muscle cell migration induced by TNF-a through inhibition of matrix metalloproteinase-2 and -9 activity. Vascular Pharmacology 41 (2004) 83-90
7. Hotary K.B., Allen E.D., Brooks P.C., Datta N.S., Long M.W., and Weiss S.J. Membrane Type I matrix metalloproteinase usurps tumor growth control imposed by the three-dimensional extracellular matrix. Cell 114 (2003) 33-45
8. Hurst D.R., Schwartz M.A., Ghaffari M.A., Jin Y., Tschesche H., Fields G.B., and Sang Q.X. Catalytic- and ecto-domains of membrane type 1-matrix metalloproteinase have similar inhibition profiles but distinct endopeptidase activities. Biochemical Journal 377 (2004) 775-779
9. Johnson L.L., Dyer R., and Hupe D.J. Matrix metalloproteinases. Current Opinion in Chemical Biology 2 (1998) 466-471
10. Mathieu J. Herb and cancer treatment. Journal of The American Dietetic Association 105 (2005) 22-24
11. Ni H., Zhang Z., and Fu H. Research and development of Fructus gardeniae. China Journal of Chinese Materia Mediea 31 (2006) 537-541
12. Ouyang H., and Liu Y. Review of qingkailing injection on clinical application. Strait Pharmaceutica1 Journa1 17 (2005) 121-125
13. Overall C.M., and López-Otín C. Strategies for MMP inhibition in cancer: innovations for the post-trial era. Nature Reviews Cancer 2 (2002) 657-672
14. Pang A., and Wei Y. Clinical study on qingkailing injection in treating rheumatoid arthritis at active stage. Shandong Journal of Traditional Chinese Medicine 21 (2002) 267-269
15. Park W.H., Kim S.H., and Kim C.H. A new matrix metalloproteinase-9 inhibitor 3,4-dihydroxycinnamic acid (caffeic acid) from methanol extract of Euonymus alatus: isolation and structure determination. Toxicology 207 (2005) 383-390
16. Shi X., Jin F., Wang H., Yang J., Wang Z., and Fang X. Expression optimization and characterization of the catalytic domain of human MT3-MMP. Chemical Research in Chinese Universities 22 (2006) 129-133
17. Spinale F.G., Coker M.L., Krombach S.R., Mukherjee R., Hallak H., Houck W.V., Clair M.J., Kribbs S.B., Johnson L.L., Peterson J.T., and Zile M.R. Matrix metalloproteinase inhibition during the development of congestive heart failure: effects on left ventricular dimensions and function. Circulation Research 85 (1999) 364-376
18. Stricklin G.P., and Welgus H.G. Human skin fibroblast collagenase inhibitor. Purification and biochemical characterization. Journal of Biological Chemistry 258 (1983) 12252-12258
19. Tang W., Hemm I., and Bertram B. Recent development of antitumor agents from Chinese herbal medicines; part I. Low molecular compounds. Planta Medica 69 (2003) 97-108
20. Tonn J.C., Kerkau S., Hanke A., Bouterfa H., Mueller J.G., Wagner S., Vince G.H., and Roosen K. Effect of synthetic matrix metalloproteinase inhibitors on invasive capacity and proliferation of human malignant gliomas in vitro. International Journal of Cancer 80 (1999) 764-772
21. Yoshihara Y., Nakamura H., Obata K., Yamada H., Hayakawa T., Fujikawa K., and Okada Y. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids from patients with rheumatoid arthritis or osteoarthritis. Annals of The Rheumatic Diseases 59 (2000) 455-461